144 related articles for article (PubMed ID: 17646162)
1. The neurodegenerative disease protein ataxin-1 antagonizes the neuronal survival function of myocyte enhancer factor-2.
Bolger TA; Zhao X; Cohen TJ; Tsai CC; Yao TP
J Biol Chem; 2007 Oct; 282(40):29186-92. PubMed ID: 17646162
[TBL] [Abstract][Full Text] [Related]
2. The deacetylase HDAC4 controls myocyte enhancing factor-2-dependent structural gene expression in response to neural activity.
Cohen TJ; Barrientos T; Hartman ZC; Garvey SM; Cox GA; Yao TP
FASEB J; 2009 Jan; 23(1):99-106. PubMed ID: 18780762
[TBL] [Abstract][Full Text] [Related]
3. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
Cummings CJ; Orr HT; Zoghbi HY
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
[TBL] [Abstract][Full Text] [Related]
4. The role of LANP and ataxin 1 in E4F-mediated transcriptional repression.
Cvetanovic M; Rooney RJ; Garcia JJ; Toporovskaya N; Zoghbi HY; Opal P
EMBO Rep; 2007 Jul; 8(7):671-7. PubMed ID: 17557114
[TBL] [Abstract][Full Text] [Related]
5. USP7, a ubiquitin-specific protease, interacts with ataxin-1, the SCA1 gene product.
Hong S; Kim SJ; Ka S; Choi I; Kang S
Mol Cell Neurosci; 2002 Jun; 20(2):298-306. PubMed ID: 12093161
[TBL] [Abstract][Full Text] [Related]
6. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.
Klement IA; Skinner PJ; Kaytor MD; Yi H; Hersch SM; Clark HB; Zoghbi HY; Orr HT
Cell; 1998 Oct; 95(1):41-53. PubMed ID: 9778246
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2.
Grégoire S; Xiao L; Nie J; Zhang X; Xu M; Li J; Wong J; Seto E; Yang XJ
Mol Cell Biol; 2007 Feb; 27(4):1280-95. PubMed ID: 17158926
[TBL] [Abstract][Full Text] [Related]
8. HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3.
Chou AH; Chen SY; Yeh TH; Weng YH; Wang HL
Neurobiol Dis; 2011 Feb; 41(2):481-8. PubMed ID: 21047555
[TBL] [Abstract][Full Text] [Related]
9. Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4.
Backs J; Worst BC; Lehmann LH; Patrick DM; Jebessa Z; Kreusser MM; Sun Q; Chen L; Heft C; Katus HA; Olson EN
J Cell Biol; 2011 Oct; 195(3):403-15. PubMed ID: 22042619
[TBL] [Abstract][Full Text] [Related]
10. Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors.
Tsai CC; Kao HY; Mitzutani A; Banayo E; Rajan H; McKeown M; Evans RM
Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4047-52. PubMed ID: 15016912
[TBL] [Abstract][Full Text] [Related]
11. Direct interaction between myocyte enhancer factor 2 (MEF2) and protein phosphatase 1alpha represses MEF2-dependent gene expression.
Perry RL; Yang C; Soora N; Salma J; Marback M; Naghibi L; Ilyas H; Chan J; Gordon JW; McDermott JC
Mol Cell Biol; 2009 Jun; 29(12):3355-66. PubMed ID: 19364819
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of an amino-terminal region of HDAC4 that possesses MEF2 binding and transcriptional repressive activity.
Chan JK; Sun L; Yang XJ; Zhu G; Wu Z
J Biol Chem; 2003 Jun; 278(26):23515-21. PubMed ID: 12709441
[TBL] [Abstract][Full Text] [Related]
13. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5.
McKinsey TA; Zhang CL; Olson EN
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14400-5. PubMed ID: 11114197
[TBL] [Abstract][Full Text] [Related]
14. Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4.
Youn HD; Grozinger CM; Liu JO
J Biol Chem; 2000 Jul; 275(29):22563-7. PubMed ID: 10825153
[TBL] [Abstract][Full Text] [Related]
15. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures.
Skinner PJ; Koshy BT; Cummings CJ; Klement IA; Helin K; Servadio A; Zoghbi HY; Orr HT
Nature; 1997 Oct; 389(6654):971-4. PubMed ID: 9353120
[TBL] [Abstract][Full Text] [Related]
16. Suppression of a MEF2-KLF6 survival pathway by PKA signaling promotes apoptosis in embryonic hippocampal neurons.
Salma J; McDermott JC
J Neurosci; 2012 Feb; 32(8):2790-803. PubMed ID: 22357862
[TBL] [Abstract][Full Text] [Related]
17. Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications.
Zhao X; Sternsdorf T; Bolger TA; Evans RM; Yao TP
Mol Cell Biol; 2005 Oct; 25(19):8456-64. PubMed ID: 16166628
[TBL] [Abstract][Full Text] [Related]
18. dAtaxin-2 mediates expanded Ataxin-1-induced neurodegeneration in a Drosophila model of SCA1.
Al-Ramahi I; Pérez AM; Lim J; Zhang M; Sorensen R; de Haro M; Branco J; Pulst SM; Zoghbi HY; Botas J
PLoS Genet; 2007 Dec; 3(12):e234. PubMed ID: 18166084
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase A-regulated assembly of a MEF2{middle dot}HDAC4 repressor complex controls c-Jun expression in vascular smooth muscle cells.
Gordon JW; Pagiatakis C; Salma J; Du M; Andreucci JJ; Zhao J; Hou G; Perry RL; Dan Q; Courtman D; Bendeck MP; McDermott JC
J Biol Chem; 2009 Jul; 284(28):19027-42. PubMed ID: 19389706
[TBL] [Abstract][Full Text] [Related]
20. SUMOylation of the polyglutamine repeat protein, ataxin-1, is dependent on a functional nuclear localization signal.
Riley BE; Zoghbi HY; Orr HT
J Biol Chem; 2005 Jun; 280(23):21942-8. PubMed ID: 15824120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
